BN Business News
Engadir empresa →

Business · 18/11/20261 min read

O socio de Harbour BioMed, Spruce Biosciences, separa o programa CRHX-101 en Adrenyx Biosciences, avanzando no desenvolvemento do anticorpo orixinado por Harbour BioMed a través dunha empresa independente

Local automatic translation · Lingua orixinal da fonte

EDITORIAL ILLUSTRATIONBBusinessBN
Illustration generated by Business News; it is not a source photograph.

Summary

CAMBRIDGE, Mass., ROTTERDAM, Países Baixos e SHANGHAI, Nov.

Lingua orixinal da fonte: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →